GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in en: translated_label)
(‎Added qualifier: readability score (P590521): 0.000011549083729174788)
 
(14 intermediate revisions by the same user not shown)
label / frlabel / fr
 
GLYCO-IBD: Les glycanes en tant que nouveaux immunomodulateurs dans les maladies inflammatoires de l’intestin: Une opportunité pour de nouvelles stratégies thérapeutiques.
label / delabel / de
 
GLYCO-IBD: Glykane als neue Immunmodulatoren bei entzündlichen Darmerkrankungen: Eine Chance für neue therapeutische Strategien.
label / nllabel / nl
 
GLYCO-IBD: Glycanen als nieuwe immunomodulatoren bij inflammatoire darmziekte: Een kans voor nieuwe therapeutische strategieën.
label / itlabel / it
 
GLYCO-IBD: Glicani come nuovi immunomodulatori nella malattia infiammatoria intestinale: Un'opportunità per nuove strategie terapeutiche.
label / eslabel / es
 
GLYCO-IBD: Glicanos como nuevos inmunomoduladores en la enfermedad inflamatoria intestinal: Una oportunidad para nuevas estrategias terapéuticas.
label / etlabel / et
 
GLYCO-IBD: Glükaanid kui uued immunomodulaatorid põletikulise soolehaiguse korral: Võimalus uuteks terapeutilisteks strateegiateks.
label / ltlabel / lt
 
GLYCO-IBD: Glikonai kaip nauji imunomoduliatoriai uždegiminei žarnyno ligai gydyti: Naujų gydymo strategijų galimybė.
label / hrlabel / hr
 
GLYCO-IBD: Glikoni kao novi imunomodulatori u upalnoj bolesti crijeva: Prilika za nove terapijske strategije.
label / ellabel / el
 
GLYCO-IBD: Γλυκάνες ως νέοι ανοσοδιαμορφωτές σε φλεγμονώδη νόσο του εντέρου: Μια ευκαιρία για νέες θεραπευτικές στρατηγικές.
label / sklabel / sk
 
GLYCO-IBD: Glykány ako nové imunomodulátory pri zápalovom ochorení čriev: Príležitosť na nové terapeutické stratégie.
label / filabel / fi
 
GLYCO-IBD: Glykaanit uutena immunomodulaattorina tulehduksellisessa suolistosairaudessa: Mahdollisuus uusiin terapeuttisiin strategioihin.
label / pllabel / pl
 
GLYCO-IBD: Glikany jako nowe immunomodulatory w zapalnej chorobie jelita: Szansa na nowe strategie terapeutyczne.
label / hulabel / hu
 
GLYCO-IBD: Glikánok, mint új immunmodulátorok gyulladásos bélbetegségben: Egy lehetőség az új terápiás stratégiákra.
label / cslabel / cs
 
GLYCO-IBD: Glykany jako nové imunomodulátory u zánětlivého onemocnění střev: Příležitost pro nové terapeutické strategie.
label / lvlabel / lv
 
GLYCO-IBD: Glikāni kā jauni imūnmodulatori iekaisīgas zarnu slimības gadījumā: Iespēja jaunām terapeitiskām stratēģijām.
label / galabel / ga
 
GLYCO-IBD: Glycans mar imdhíonmhálaithe nua i ngalar bputóg athlastach: Deis do straitéisí teiripeacha nua.
label / sllabel / sl
 
GLYCO-IBD: Glikani kot novi imunomodulatorji pri vnetni črevesni bolezni: Priložnost za nove terapevtske strategije.
label / bglabel / bg
 
GLYCO-IBD: Глицините като нови имуномодулатори при възпалително заболяване на червата: Възможност за нови терапевтични стратегии.
label / mtlabel / mt
 
GLYCO-IBD: Glycans bħala immunomodulaturi ġodda f’mard infjammatorju tal-musrana: Opportunità għal strateġiji terapewtiċi ġodda.
label / dalabel / da
 
GLYCO-IBD: Glycaner som nye immunmodulatorer i inflammatorisk tarmsygdom: En mulighed for nye terapeutiske strategier.
label / rolabel / ro
 
GLYCO-IBD: Glicanii ca imunomodulatori noi în boala inflamatorie intestinală: O oportunitate pentru noi strategii terapeutice.
label / svlabel / sv
 
GLYCO-IBD: Glycaner som nya immunmodulerare vid inflammatorisk tarmsjukdom: En möjlighet till nya terapeutiska strategier.
description / bgdescription / bg
 
Проект Q2905968 в Португалия
description / hrdescription / hr
 
Projekt Q2905968 u Portugalu
description / hudescription / hu
 
Projekt Q2905968 Portugáliában
description / csdescription / cs
 
Projekt Q2905968 v Portugalsku
description / dadescription / da
 
Projekt Q2905968 i Portugal
description / nldescription / nl
 
Project Q2905968 in Portugal
description / etdescription / et
 
Projekt Q2905968 Portugalis
description / fidescription / fi
 
Projekti Q2905968 Portugalissa
description / frdescription / fr
 
Projet Q2905968 au Portugal
description / dedescription / de
 
Projekt Q2905968 in Portugal
description / eldescription / el
 
Έργο Q2905968 στην Πορτογαλία
description / gadescription / ga
 
Tionscadal Q2905968 sa Phortaingéil
description / itdescription / it
 
Progetto Q2905968 in Portogallo
description / lvdescription / lv
 
Projekts Q2905968 Portugālē
description / ltdescription / lt
 
Projektas Q2905968 Portugalijoje
description / mtdescription / mt
 
Proġett Q2905968 fil-Portugall
description / pldescription / pl
 
Projekt Q2905968 w Portugalii
description / ptdescription / pt
 
Projeto Q2905968 em Portugal
description / rodescription / ro
 
Proiectul Q2905968 în Portugalia
description / skdescription / sk
 
Projekt Q2905968 v Portugalsku
description / sldescription / sl
 
Projekt Q2905968 na Portugalskem
description / esdescription / es
 
Proyecto Q2905968 en Portugal
description / svdescription / sv
 
Projekt Q2905968 i Portugal
Property / budget
166,566.0 Euro
Amount166,566.0 Euro
UnitEuro
 
Property / budget: 166,566.0 Euro / rank
Normal rank
 
Property / co-financing rate
66.0 percent
Amount66.0 percent
Unitpercent
 
Property / co-financing rate: 66.0 percent / rank
Normal rank
 
Property / start time
1 July 2016
Timestamp+2016-07-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / start time: 1 July 2016 / rank
Normal rank
 
Property / beneficiary name (string)
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
 
Property / beneficiary name (string): IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO / rank
Normal rank
 
Property / beneficiary
Q2993205 (Deleted Item)
 
Property / beneficiary: Q2993205 (Deleted Item) / rank
Normal rank
 
Property / summary
 
None (Estonian)
Property / summary: None (Estonian) / rank
 
Normal rank
Property / summary: None (Estonian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Lithuanian)
Property / summary: None (Lithuanian) / rank
 
Normal rank
Property / summary: None (Lithuanian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Italian)
Property / summary: None (Italian) / rank
 
Normal rank
Property / summary: None (Italian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (French)
Property / summary: None (French) / rank
 
Normal rank
Property / summary: None (French) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Croatian)
Property / summary: None (Croatian) / rank
 
Normal rank
Property / summary: None (Croatian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Greek)
Property / summary: None (Greek) / rank
 
Normal rank
Property / summary: None (Greek) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (English)
Property / summary: None (English) / rank
 
Normal rank
Property / summary: None (English) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary: None (English) / qualifier
 
readability score: 0.000011549083729174788
Amount0.000011549083729174788
Unit1
Property / summary
 
None (Slovak)
Property / summary: None (Slovak) / rank
 
Normal rank
Property / summary: None (Slovak) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Finnish)
Property / summary: None (Finnish) / rank
 
Normal rank
Property / summary: None (Finnish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Polish)
Property / summary: None (Polish) / rank
 
Normal rank
Property / summary: None (Polish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Hungarian)
Property / summary: None (Hungarian) / rank
 
Normal rank
Property / summary: None (Hungarian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Dutch)
Property / summary: None (Dutch) / rank
 
Normal rank
Property / summary: None (Dutch) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Czech)
Property / summary: None (Czech) / rank
 
Normal rank
Property / summary: None (Czech) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Latvian)
Property / summary: None (Latvian) / rank
 
Normal rank
Property / summary: None (Latvian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Irish)
Property / summary: None (Irish) / rank
 
Normal rank
Property / summary: None (Irish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Slovenian)
Property / summary: None (Slovenian) / rank
 
Normal rank
Property / summary: None (Slovenian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Spanish)
Property / summary: None (Spanish) / rank
 
Normal rank
Property / summary: None (Spanish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Bulgarian)
Property / summary: None (Bulgarian) / rank
 
Normal rank
Property / summary: None (Bulgarian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Maltese)
Property / summary: None (Maltese) / rank
 
Normal rank
Property / summary: None (Maltese) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Portuguese)
Property / summary: None (Portuguese) / rank
 
Normal rank
Property / summary: None (Portuguese) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Danish)
Property / summary: None (Danish) / rank
 
Normal rank
Property / summary: None (Danish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Romanian)
Property / summary: None (Romanian) / rank
 
Normal rank
Property / summary: None (Romanian) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (German)
Property / summary: None (German) / rank
 
Normal rank
Property / summary: None (German) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / summary
 
None (Swedish)
Property / summary: None (Swedish) / rank
 
Normal rank
Property / summary: None (Swedish) / qualifier
 
point in time: 29 July 2022
Timestamp+2022-07-29T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / priority axis
 
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank
 
Normal rank
Property / thematic objective
 
Property / thematic objective: Research and innovation / rank
 
Normal rank
Property / start time
 
7 January 2016
Timestamp+2016-01-07T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / start time: 7 January 2016 / rank
 
Normal rank
Property / budget
 
194,768.5 Euro
Amount194,768.5 Euro
UnitEuro
Property / budget: 194,768.5 Euro / rank
 
Preferred rank
Property / EU contribution
 
165,553.23 Euro
Amount165,553.23 Euro
UnitEuro
Property / EU contribution: 165,553.23 Euro / rank
 
Preferred rank
Property / co-financing rate
 
85.0 percent
Amount85.0 percent
Unitpercent
Property / co-financing rate: 85.0 percent / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO / rank
 
Normal rank
Property / beneficiary name (string)
 
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
Property / beneficiary name (string): IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO / rank
 
Normal rank
Property / date of last update
 
14 November 2023
Timestamp+2023-11-14T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / date of last update: 14 November 2023 / rank
 
Normal rank

Latest revision as of 10:28, 20 March 2024

Project Q2905968 in Portugal
Language Label Description Also known as
English
GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies.
Project Q2905968 in Portugal

    Statements

    0 references
    165,553.23 Euro
    0 references
    194,768.5 Euro
    0 references
    85.0 percent
    0 references
    7 January 2016
    0 references
    31 December 2019
    0 references
    IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
    0 references
    None (Estonian)
    29 July 2022
    0 references
    None (Lithuanian)
    29 July 2022
    0 references
    None (Italian)
    29 July 2022
    0 references
    None (French)
    29 July 2022
    0 references
    None (Croatian)
    29 July 2022
    0 references
    None (Greek)
    29 July 2022
    0 references
    None (English)
    29 July 2022
    0.000011549083729174788
    0 references
    None (Slovak)
    29 July 2022
    0 references
    None (Finnish)
    29 July 2022
    0 references
    None (Polish)
    29 July 2022
    0 references
    None (Hungarian)
    29 July 2022
    0 references
    None (Dutch)
    29 July 2022
    0 references
    None (Czech)
    29 July 2022
    0 references
    None (Latvian)
    29 July 2022
    0 references
    None (Irish)
    29 July 2022
    0 references
    None (Slovenian)
    29 July 2022
    0 references
    None (Spanish)
    29 July 2022
    0 references
    None (Bulgarian)
    29 July 2022
    0 references
    None (Maltese)
    29 July 2022
    0 references
    None (Portuguese)
    29 July 2022
    0 references
    None (Danish)
    29 July 2022
    0 references
    None (Romanian)
    29 July 2022
    0 references
    None (German)
    29 July 2022
    0 references
    None (Swedish)
    29 July 2022
    0 references
    14 November 2023
    0 references

    Identifiers

    POCI-01-0145-FEDER-016601
    0 references